Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Do you recommend ADT for a high risk prostate cancer patient who had SBRT?
If so, how long?
Answer from: Radiation Oncologist at Community Practice
SBRT doesn’t mitigate benefit of ADT and the type and duration have to be the same as with EBRT or EBRT plus brachytherapy.
Comments
Radiation Oncologist at Genesis Healthcare Partners- San Diego
Since ADT has no benefit in high risk prostate ca ...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Ma et al., PMID 35934601 This article highlight...
6993
6998
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
I would not treat a high risk patient with SBRT.
Sign in or Register to read more
14207
14233
Related Questions
If a patient diagnosed with seminoma after orchiectomy has margin positive disease noted in the spermatic cord and no overt metastasis on imaging and normal tumor markers, how should this patient be staged?
What data support the use of continuing GnRH therapy "backbone" in metastatic castration resistant prostate cancer (mCRPC) receiving additional therapies?
Would you ever omit or reduce prostate bed radiation in a post-prostatectomy patient who develops recurrence in pelvic LNs?
What duration androgen deprivation do you recommend with salvage pelvic radiotherapy for pelvic node relapse after prostatectomy?
In what situations would a standard FDG PET/CT be useful in the evaluation of high risk prostate cancer?
Do you offer RT both to the prostate and synchronous oligometastases in de novo oligometastatic prostate cancer?
Do you need renal biopsy before SBRT for RCC suspicious cancer?
How do you approach a non-classical metastatic prostate cancer?
Is there any way to safely treat patients with mCRPC with 177-Lu PSMA who are on hemodialysis?
Does a negative staging PSMA PET in a patient with biopsy-proven recurrent prostatic adenocarcinoma change your management?
Since ADT has no benefit in high risk prostate ca ...
Ma et al., PMID 35934601 This article highlight...